Novel anti-inflammatory compound SEN1176 alleviates behavioral deficits induced following bilateral intrahippocampal injection of aggregated amyloid-β1-42

Journal of Alzheimer's Disease

Volumn 25, Issue 2, 2011, Pages 219-229

  O'Hare, Eugene ^a   Scopes, David I C ^b   Treherne, J Mark ^b   Monaghan, John ^c   Palmer, Philip M ^a   Amijee, Hozefa ^b   Kim, Eun Mee ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Senexis Limited   (United Kingdom)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Alzheimer's disease; amyloid ; behavior; inflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ANTIINFLAMMATORY AGENT; SEN 1176; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BEHAVIOR DISORDER; CONTROLLED STUDY; LEARNING; MALE; MEMORY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

EID: 79960733294     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-100044     Document Type: Article

References (67)

1. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193. (Pubitemid 39348839)
2. Walsh DM, Selkoe DJ (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegener-ation. Protein Pept Lett 11, 213-228. (Pubitemid 38689025)
3. Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN (2004) The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?. Pharmacol Res 50, 397-409. (Pubitemid 39078531)
4. Tanzi RE, Moir RD, Wagner SL (2004) Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43, 605-608. (Pubitemid 39179722)
5. Amijee H, Scopes DIC (2009) The quest for small molecules as amyloid inhibiting therapies for Alzheimer's disease. J Alzheimers Dis 17, 33-47.
6. Rosemuller JM, Eikelenboom P, Stern FC (1986) Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 51, 247-254. (Pubitemid 16084111)
7. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system. Neurobiol Aging 9, 339-349.
8. Haga S, Akai K, Ishii T (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 77, 569-575. (Pubitemid 19125369)
9. Perfmutter LS, Scott SA, Barron B, Chui HC (1992) MHC class II-positive microglia in human brain: association with Alzheimer lesions. J Neurosci Res 33, 549-558.
10. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B (1992) Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66, 223-230.
11. Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer's disease: interleukin-1 beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha 1-antichymotrypsin. Alzheimer Dis Assoc Discord 12, 215-227. (Pubitemid 29154993)
12. Overmyer M, Helisalmi S, Soininen H, Lasko M, Riekkinen SP, Alafuzoff I (1999) Reactive microglia in aging and dementia: an immunohistochemical study of post-mortem human brain tissue. Acta Neuropathol 97, 383-392. (Pubitemid 29134519)
13. Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ (2008) Microglia, amyloid and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11]PIB-PET study. Neurobiol Dis 32, 412-419.
14. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW (2007) Inflammatory changes parallel the early stages of Alzheimer's disease. Neurobiol Aging 28, 1821-1833. (Pubitemid 47539700)
15. Ishi T, Haga S (1984) Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol 63, 296-300. (Pubitemid 14080924)
16. Yasojima K, Schwab C, McGeer EG, McGeer PL (1999) Up-regulated production and activation of the compliment system in Alzheimer's disease brain. Am J Pathol 154, 927-936. (Pubitemid 29122612)
17. Bronotis K, Krikki E, Holeva V, Aggouridaki C, Costa V, Baloyannis S (2007) Systemic immune aberrations in Alzheimer's disease patients. JNeuroimmunol 193, 183-187.
18. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Safrani E, Suarez T, Chiappelli F, Bernard G (2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis 7, 221-232. (Pubitemid 40917251)
19. McGeer EG, McGeer PL (2010) Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis 19, 355-361.
20. Combs CK (2009) Inflammation and microglia actions in Alzheimer's disease. JNeuroimmune Pharmacol 4, 380-388.
21. Cameron B, Landreth GE (2010) Inflammation, microglia and Alzheimer's disease. Neurobiol Dis 37, 503-509.
22. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel A, Murphy GM Jr, Bradida L, Yan SD, Walker DG, Shen Y, Rogers J (2001) Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35, 72-79. (Pubitemid 32656755)
23. Araujo DM, Cotman CW (1992) fj-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 569, 141
24. Bauer J, Ganter U, Strauss G, Stadmuller G, Frommberger U, Bauer H, Volk B, Berger M (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 143, 650-657.
25. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol 56, 259-262. (Pubitemid 19049180)
26. Griffin WTS, Stanley LC, Ling C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 86, 7611-7615. (Pubitemid 19254506)
27. Mandybur TI, Chuirizzi BA (1990) Astrocytes and the plaques of Alzheimer's disease. Neurology 40, 635-639. (Pubitemid 20139091)
28. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Immune system response in Alzheimer's disease. Can J Neurol Sci 16, 516-527. (Pubitemid 19278363)
29. McGeer PL, Kawamata T, Walker DG, Akyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7, 84-92.
30. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21, 195-218. (Pubitemid 26061873)
31. O'Hare E, Weldon DT, Mantyh PW, Ghilardi JR, Finke MP, Kuskowski MA, Maggio JE, Shephard RA, Cleary J (1999) Delayed behavioural effects following intrahippocam-pal injection of aggregated Afj(1-42). Brain Res 815, 1-10. (Pubitemid 29225218)
32. Webster S, Lue L-F, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J (1997) Molecular and cellular characterization of the membrane attack complex C5b-9, in Alzheimer's disease. Neurobiol Aging 18, 415-421. (Pubitemid 27436086)
33. Kalaria RN (1999) Microglia and Alzheimer's disease. Curr Opin Hematol 6, 15-24. (Pubitemid 29069007)
34. Aklyama H, Barger S, Bradt B, Bauer J, Cole GM, Cooper NR, Elkelenboom P, Emmerling M, Fiebich BI, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Makenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma L et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421. (Pubitemid 30349107)
35. Elkelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ (2006) The significance of neuroin-flammation in understanding Alzheimer's disease. J Neural Transm113, 1685-1695. (Pubitemid 44657664)
36. Griffin WS (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83, 4705-4745.
37. Broe GA, Henderson AS, Creasey H (1990) A case-control study of Alzheimer's disease in Australia. Neurology 40, 1698-1707. (Pubitemid 20383135)
38. Jenkinson MI, Bliss MR, Brain AT, Scott DL (1988) Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br J Rheumatol 28, 86-88.
39. Moore AH, Bigbee MJ, Boynton GE, Wakeham CM, Rosenheim HM, Staral CJ, Morrissey JL, Hund AK (2010) Non-steroidal anti-inflammatory drugs in Alzheimer's disease and Parkinson's disease: reconsidering the role of neuroin-flammation. Pharmaceuticals 3, 1812-1841.
40. Sastre M, Gentleman SM (2010) NSAIDs: how they work and their prospects as therapeutics in Alzheimer's disease. Front Ag Neurosci 2, 1-6.
41. Imbimbo BP (2009) An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Exp Opin Invest Drugs 18, 1147-1168.
42. Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald MW, Helms MJ, Anthony JC (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44, 227-232. (Pubitemid 24070956)
43. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45, 51-55.
44. Beard CM, Waring SC, O'Brien PC, Kurland LT, Kok-men E (1984) Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case control study in Rochester, Minnesota, 1980 through 1984. Mayo Clin Proc 73, 951-955.
45. Landi F, Cesari M, Onder G, Russo A, Torre S, Bern-abei R (2003) Nonsteroidal anti-inflammatory drug (NSAID) use and Alzheimer's disease in community-dwelling elderly patients. Am J Geriatr Psychiatry 11, 179-185. (Pubitemid 36254191)
46. Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23, 159-169. (Pubitemid 38980441)
47. Int'Veld VA, Ruitenberg A, Hofman A, Launer LI, van Duijin CM, Stijnen T, Breteler MM, Stricker BH (2001) Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345, 1515-1521. (Pubitemid 33144916)
48. Zandi PP, Anthony JC, Hayden KM, Mehata K, Mayer L, Breitner JC (2002) Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59, 880-886.
49. Bacher M, Dodel R, Aljaban B, Keyvani K, Marambaud P, Kayed R, Glabe C, Goertz N, Hoppmann A, Sachser N, Klotsche J, Schnell S, Lewejohann L, Al-Abed Y (2008) CNI-1493 inhibits Abeta production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease. J Exp Med 205, 1593-1599. (Pubitemid 351962023)
50. Richardson RL, Kim E-M, Shephard RA, Gardiner T, Cleary J, O'Hare E (2002) Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated A(3(1-42) injections in the rat. Brain Res 954, 1-10. (Pubitemid 35230002)
51. McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer's disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28, 639-647. (Pubitemid 46349357)
52. Zotova E, Nicoll JAR, Kalria R, Boche D (2010) Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alz Res Ther 2, 1-9.
53. Uryu S, Tokuhiro S, Oda T (2002) A novel compound, RS-1178, specifically inhibits neuronal cell death mediated by beta-amyloid-induced macrophage activation in vitro. Brain Res 946, 298-306. (Pubitemid 34876343)
54. Weldon DT, O'Hare E, Kuskowski MA, Cleary J, Mach JR Jr (1996) Alternating-lever cyclic-ratio schedule analysis of the effects of atropine sulphate. Pharmacol Biochem Behav 54, 753-757. (Pubitemid 26258660)
55. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid- fj protein specifically disrupt cognitive function. Nat Neurosci 8, 79-84. (Pubitemid 41236735)
56. Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O'Hare E, Walsh DM, Selkoe DJ (2006) Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann Neurol 60, 668-676. (Pubitemid 46048484)
57. Poling A, Morgan-Paisley K, Panos KJ, Kim E-M, O'Hare E, Cleary JP, Lesne S, Ashe KH, Porritt M, Baker LE (2008) Oligomers of the amyloid-fj protein disrupt working memory: confirmation with two behavioural procedures. Behav Brain Res 193, 230-234.
58. O'Hare E, Scopes DIC, Treherne JM, Norwood K, Spanswick D, Kim E-M (2010) RS-0406 arrests amyloid-fj oligomer-induced behavioural deterioration in vivo. Behav Brain Res 210, 32-37.
59. Kim E-M, Elliott JJ, Hobson P, O'Hare E (2009) Effects of intrahippocampal NAC61-95 injections on memory in the rat and attenuation with vitamin E. Prog Neuropsychopharmacol Biol Psychiatry 33, 945-951.
60. O'Hare E, Elliott JJ, Hobson P, O'Mara SM, Spanswick D, Kim E-M (2009) Bilateral intrahippocampal NAC61-95 effects on behaviour and moderation with L-NAME treatment. Neurosci Res 66, 213-218.
61. O'Hare E, Elliott JJ, Hobson P, Spanswick D, Kim E-M (2009) Behavioural deterioration induced by intrahippocam- pal NAC61-95 injections and attenuation with ibuprofen. Behav Brain Res 208, 274-277.
62. Esler WP, Stimson ER, Ghilardi JR, Felix AM, Lu Y, Vin- ters HV, Mantyh PW, Maggion JE (1997) A-beta deposition inhibitor screen using synthetic amyloid. Nat Biotech 15, 258-263. (Pubitemid 27118271)
63. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego.
64. Canning DR, McKeown RJ, De Witt DA, Perry G, Wujek JR, Frederickson RC, Silver J (1993) fj-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 124, 289-298.
65. Hoke A, Canning DR, Malemud CJ, Silver J (1994) Regional differences in reactive gliosis induced by substrate-bound fj-amyloid. Exp Neurol 130, 56-66.
66. Pike CJ, Cummings BJ, Monzavi R, Cottman CW (1994) fj-Amyloid induces changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63, 517-531.
67. Sigurdsson EM, Lee JM, Dong XW, Hejna SJ, Lorens SA (1997) Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neurobiol Aging 18, 591-608.